Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Benatar

Showing results (141-150 of 242) with videos related to

Pageof 25
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 6, 2017
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteriaMichael J Strong, Sharon Abrahams, Laura H Goldstein, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 26, 2023
ALSUntangled #71: NuedextaYuyao Sun, Michael Benatar, Javier Mascías Cadavid, et al.
Neuroimage. Clinical|June 18, 2024
Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging studyHans-Peter Müller, Agessandro Abrahao, Christian Beaulieu, et al.
Human Brain Mapping|October 3, 2025
Divergent Brain Network Activity in Asymptomatic C9orf72 and SOD1 Variant Carriers Compared With Established Amyotrophic Lateral SclerosisMichael Trubshaw, Chetan Gohil, Evan Edmond, et al.
The Lancet. Neurology|June 23, 2023
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Michael Benatar, Metin Kurtoglu, et al.
Neurology. Genetics|June 22, 2023
Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in AfricansNomakhosazana R Monnakgotla, Amokelani C Mahungu, Jeannine M Heckmann, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 22, 2018
Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case reportCyril Pottier, Evadnie Rampersaud, Matt Baker, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2025
Predicting Phenoconversion to Clinically Manifest ALS: Results of a Large-Scale Proteomic StudyXiming Ran, Joanne Wuu, Zhaohui S Qin, et al.
Neurology|November 4, 2020
International Consensus Guidance for Management of Myasthenia Gravis: 2020 UpdatePushpa Narayanaswami, Donald B Sanders, Gil Wolfe, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
Pageof 25

Showing results (141-150 of 242) with videos related to

Sort By:
Pageof 25
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 6, 2017
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteriaMichael J Strong, Sharon Abrahams, Laura H Goldstein, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 26, 2023
ALSUntangled #71: NuedextaYuyao Sun, Michael Benatar, Javier Mascías Cadavid, et al.
Neuroimage. Clinical|June 18, 2024
Temporal and spatial progression of microstructural cerebral degeneration in ALS: A multicentre longitudinal diffusion tensor imaging studyHans-Peter Müller, Agessandro Abrahao, Christian Beaulieu, et al.
Human Brain Mapping|October 3, 2025
Divergent Brain Network Activity in Asymptomatic C9orf72 and SOD1 Variant Carriers Compared With Established Amyotrophic Lateral SclerosisMichael Trubshaw, Chetan Gohil, Evan Edmond, et al.
The Lancet. Neurology|June 23, 2023
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a studyVolkan Granit, Michael Benatar, Metin Kurtoglu, et al.
Neurology. Genetics|June 22, 2023
Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in AfricansNomakhosazana R Monnakgotla, Amokelani C Mahungu, Jeannine M Heckmann, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 22, 2018
Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case reportCyril Pottier, Evadnie Rampersaud, Matt Baker, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2025
Predicting Phenoconversion to Clinically Manifest ALS: Results of a Large-Scale Proteomic StudyXiming Ran, Joanne Wuu, Zhaohui S Qin, et al.
Neurology|November 4, 2020
International Consensus Guidance for Management of Myasthenia Gravis: 2020 UpdatePushpa Narayanaswami, Donald B Sanders, Gil Wolfe, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
Pageof 25